Aclaris Therapeutics Inc. (ACRS)
1.59
-0.03 (-1.85%)
At close: Mar 28, 2025, 3:17 PM
Aclaris Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -132.06M | -88.48M | -86.91M | -90.86M | -51.02M | -161.35M | -132.74M | -68.52M | -48.08M | -20.56M | -8.52M | -5.24M |
| Depreciation & Amortization | 807K | 863K | 797K | 923K | 1.32M | 6.41M | 1.88M | 402K | 120K | 90K | 12K | 11K |
| Stock-Based Compensation | 10.86M | 20.54M | 15.04M | 14.06M | 11.21M | 16.18M | 20.05M | 14.43M | 6.1M | 891K | 27K | n/a |
| Other Working Capital | 15.13M | 10.68M | -1.7M | -5.15M | -2.04M | 661K | 6.75M | -3.7M | 2.44M | -712K | 22K | -1K |
| Other Non-Cash Items | 89.41M | -20.27M | 4.7M | 24.34M | 2.39M | 734K | 555K | 10.67M | 2.78M | -5K | 1K | 3K |
| Deferred Income Tax | n/a | -367K | n/a | 752K | -182K | 44.29M | n/a | -1.84M | 216K | 289K | n/a | n/a |
| Change in Working Capital | 10.92M | 9.39M | -1.2M | -1.34M | -2.36M | -2.7M | 9.44M | 865K | 4.25M | -1.07M | 841K | 302K |
| Operating Cash Flow | -20.07M | -78.33M | -67.57M | -52.13M | -38.63M | -96.44M | -100.81M | -54.66M | -34.6M | -20.37M | -7.64M | -4.92M |
| Capital Expenditures | -121K | -1.31M | -605K | -308K | -453K | -1.61M | -1.36M | -1.24M | -232K | -507K | -417K | n/a |
| Acquisitions | n/a | n/a | -13.23M | 167.32M | -6.84M | 34.19M | -67.12M | -9.65M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -119.98M | -135.68M | -164.75M | -235.15M | -47.71M | -137.38M | -161.6M | -197.34M | -148.76M | -82.51M | -5.04M | -4.54M |
| Sales Maturities Of Investments | 86.14M | 183.2M | 177.99M | 67.83M | 54.55M | 210.49M | 239.44M | 152.53M | 87.09M | 6.07M | 3.67M | n/a |
| Other Investing Acitivies | -35.81M | n/a | 13.23M | -167.32M | 6.84M | 34.19M | 77.84M | -44.81M | -61.67M | -76.44M | -1.36M | -4.54M |
| Investing Cash Flow | -69.77M | 46.22M | 12.63M | -167.63M | 6.39M | 105.68M | 9.37M | -55.69M | -61.9M | -76.95M | -1.78M | -4.54M |
| Debt Repayment | n/a | n/a | n/a | -11.48M | 10.78M | -30.52M | 29.26M | -78K | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -377K | 86K | 123K | -1.67M | 7.6M | 207K | -1.21M | 235K | 121K | 39.86M | 10.58M | n/a |
| Financial Cash Flow | 74.54M | 26.71M | 72.87M | 225.05M | 18.37M | -30.32M | 128.26M | 100.39M | 116.83M | 96.41M | 10.58M | n/a |
| Net Cash Flow | -15.31M | -5.4M | 17.93M | 5.29M | -13.87M | -21.08M | 36.82M | -9.97M | 20.32M | -906K | 1.17M | -9.46M |
| Free Cash Flow | -20.2M | -79.63M | -68.17M | -52.44M | -39.09M | -98.06M | -102.17M | -55.9M | -34.84M | -20.88M | -8.05M | -4.92M |